Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998-2002.
about
H pylori antibiotic resistance: prevalence, importance, and advances in testingThe sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis'Rescue' therapies for the management of Helicobacter pylori infection.Treatment of Helicobacter pylori infection: current status and future concepts.Impact of clarithromycin resistance on eradication of Helicobacter pylori in infected adultsAntimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran.Molecular biology methods for the characterization of Helicobacter pylori infections and their diagnosis.Effectiveness of antiinfectives.Helicobacter pylori eradication: sequential therapy and Lactobacillus reuteri supplementation.Primary clarithromycin resistance to Helicobacter pylori: Is this the main reason for triple therapy failure?Incidence of Helicobacter pylori infection and their clarithromycin-resistant strains in otitis media with effusion regarding phenotypic and genotypic studies.Characterization of clarithromycin resistance in Malaysian isolates of Helicobacter pyloriAntimicrobial susceptibility and mutations involved in clarithromycin resistance in Helicobacter pylori isolates from patients in the western central region of Colombia.Review article: the global emergence of Helicobacter pylori antibiotic resistance.How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?Antimicrobial susceptibility of Helicobacter pylori strains isolated in BangladeshReview article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.Antimicrobial Treatment of Polymeric Medical Devices by Silver Nanomaterials and Related Technology.In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy.Double strain probiotic effect on Helicobacter pylori infection treatment: A double-blinded randomized controlled trial.Efficacy of the Combination of Tetracycline, Amoxicillin, and Lansoprazole in the Eradication of Helicobacter pylori in Treatment-Naïve Patients and in Patients Who Are Not Responsive to Clarithromycin-Based Regimens: A Pilot Study.Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents.High prevalence and level of resistance to metronidazole, but lack of resistance to other antimicrobials in Helicobacter pylori, isolated from a multiracial population in Kuwait.Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori.Most Helicobacter pylori strains of Kolkata in India are resistant to metronidazole but susceptible to other drugs commonly used for eradication and ulcer therapy.How effective is moxifloxacin for the first-line treatment of patients with Helicobacter pylori infection?Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan real-time polymerase chain reaction.Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection.The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in ItalyEvolving therapy for Helicobacter pylori infection
P2860
Q24685864-24D99F9C-8ADA-41C1-B7F9-85BD3E624829Q33287535-D0FC6FFD-CB27-4014-BBFF-668F45BD7D4CQ33371187-3EF351A1-9F83-43F6-B0AE-50DB76BD8F51Q33594850-DAFA856B-E380-4823-8DBC-8EC227872B57Q33722146-E63CE89D-68BB-4363-8ED8-B7555C04DCD7Q34385180-7D1641AF-3B75-4411-8598-6CF6021060E0Q36028541-8F9B264D-9502-45BD-98AC-CE9D837B88B8Q36222718-9F1EF5A2-BF95-4F28-8CBD-2B04EBAE9B11Q36410382-B3C01546-8410-4A9F-A83A-2C0F47E8BB3DQ37087009-020150B0-2E64-47D6-882F-8F2E534EB4C3Q37099322-DA53C928-4F46-4235-BB5B-9945D15A18C8Q37250377-42CFF33F-126B-4F40-8652-90BF0435E578Q37333166-B8EA30E5-BCB1-41F1-B58F-A07CF01A4250Q37340339-F237B6F9-3FDC-40E9-8F7D-DB2DEFCA3105Q37378899-EF5D3E5D-2E99-4C9D-8F7B-72FE561668F7Q37576098-045227B6-F268-4647-9D02-074141BAF908Q37948164-2EDC0A10-D9EA-4796-97ED-58DC715D8659Q39140815-DEEADAE9-EADF-47A1-9642-6A60B496CE7BQ40915777-FB84997B-EAAB-449A-BA6F-3CCB03F6249DQ41187439-3E5F7C43-FDC2-46EE-8B5C-D78A726AC649Q41552133-7FAFB7D8-71C5-42AF-8D8A-4168D323B73BQ43218781-09E9B513-8874-451A-90F8-E085CC5BBA98Q43699071-DE163086-6AEF-4B23-96D5-EAEACFF52B01Q44321690-CA2FCA4D-A3A2-4552-94E2-5DCD3FD2C24EQ44450540-42F5BAC7-09EA-410D-B505-313E2C0A9FF3Q46752417-E5F1660B-7E26-41D0-A383-ADC511F62056Q46901203-8F8783EC-F57F-465D-8F1A-C738ED37C20AQ46915097-346B182E-7838-4B92-AEAE-5AE0A1B7F0EBQ46923478-72489DB8-603C-442F-9EE5-626AEE47EA57Q57821493-0223D58E-A860-4A62-909B-3D70B13DCBACQ57821560-5C9D40F8-6E2B-43DC-9D77-55BA3A2B5693
P2860
Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998-2002.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Primary and secondary antibiot ...... ly during the years 1998-2002.
@en
Primary and secondary antibiot ...... ly during the years 1998-2002.
@nl
type
label
Primary and secondary antibiot ...... ly during the years 1998-2002.
@en
Primary and secondary antibiot ...... ly during the years 1998-2002.
@nl
prefLabel
Primary and secondary antibiot ...... ly during the years 1998-2002.
@en
Primary and secondary antibiot ...... ly during the years 1998-2002.
@nl
P921
P1476
Primary and secondary antibiot ...... ly during the years 1998-2002.
@en
P2093
P304
P356
10.1016/S1590-8658(03)00265-2
P577
2003-08-01T00:00:00Z